Early research (Phase 1)Study completedNCT00514306What this trial is testingStudy of Intermittent OSI-906 DosingWho this might be right forAdvanced Solid Tumors Astellas Pharma Inc 79
Early research (Phase 1)Study completedNCT00030615What this trial is testingDecitabine in Treating Patients With Advanced Solid TumorsWho this might be right forMale Breast CancerRecurrent Bladder CancerRecurrent Breast Cancer+6 more National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT04644068What this trial is testingStudy of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid MalignanciesWho this might be right forOvarian CancerBreast CancerPancreatic Cancer+10 more AstraZeneca 702
Early research (Phase 1)Study completedNCT02316509What this trial is testingGDC-0927 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast CancerWho this might be right forBreast Cancer Genentech, Inc. 43
Testing effectiveness (Phase 2)Looking for participantsNCT05579366What this trial is testingRinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)Who this might be right forHigh Grade Epithelial Ovarian CancerHigh Grade Serous Ovarian CancerPrimary Peritoneal Carcinoma+12 more Genmab 884
Early research (Phase 1)Active Not RecruitingNCT05238922What this trial is testingStudy of INCB123667 in Subjects With Advanced Solid TumorsWho this might be right forSolid Tumors Incyte Corporation 291
Not applicableStudy completedNCT01231386What this trial is testingMIRNA Profiling of Breast Cancer in Patients Undergoing Neoadjuvant or Adjuvant Treatment for Locally Advanced & Inflammatory Breast CancerWho this might be right forBreast Cancer City of Hope Medical Center 199
Early research (Phase 1)Study completedNCT03849469What this trial is testingXmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid TumorsWho this might be right forMelanomaCervical CarcinomaPancreatic Carcinoma+20 more Xencor, Inc. 78
Large-scale testing (Phase 3)Active Not RecruitingNCT00099437What this trial is testingComparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy.Who this might be right forBreast Cancer AstraZeneca 736
Testing effectiveness (Phase 2)Active Not RecruitingNCT03428802What this trial is testingPembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic InstabilityWho this might be right forBRCA1 Gene MutationBRCA2 Gene MutationLocally Advanced Solid Neoplasm+17 more Rutgers, The State University of New Jersey 21
Testing effectiveness (Phase 2)Study completedNCT01118624What this trial is testingStudy of Pralatrexate in Female Patients With Previously-treated Breast CancerWho this might be right forBreast CancerBreast TumorsNeoplasms, Breast+2 more Acrotech Biopharma Inc. 22
Testing effectiveness (Phase 2)Study completedNCT02460224What this trial is testingSafety and Efficacy of LAG525 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.Who this might be right forAdvanced Solid Tumors Novartis Pharmaceuticals 490
Large-scale testing (Phase 3)UnknownNCT05438810What this trial is testingThis is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c in Combination With Fluvestrant ± Goseraline Versus Placebo Combined With Fulvestrant ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.Who this might be right forAdvanced Breast CancerFemale Breast Cancer Ahon Pharmaceutical Co., Ltd. 312
Testing effectiveness (Phase 2)Study completedNCT00237211What this trial is testingStudy of High-dose Letrozole Therapy in Postmenopausal Patients With Breast CancerWho this might be right forPostmenopausal Women With Advanced Breast Cancer Novartis Pharmaceuticals 31
Testing effectiveness (Phase 2)WithdrawnNCT04351230What this trial is testingT-DM1 With or Without Abemaciclib for the Treatment of HER2-Positive Metastatic Breast CancerWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8HER2 Positive Breast CarcinomaMetastatic Breast Carcinoma+1 more Academic and Community Cancer Research United
Testing effectiveness (Phase 2)Looking for participantsNCT06760819What this trial is testingLearn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)Who this might be right forAdvanced Solid TumorsHER2 Mutation Bayer 111
Testing effectiveness (Phase 2)Active Not RecruitingNCT04544189What this trial is testingStudy Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Chinese Men and Postmenopausal Women With Advanced Breast CancerWho this might be right forBreast Neoplasms Novartis Pharmaceuticals 69
Testing effectiveness (Phase 2)WithdrawnNCT00006123What this trial is testingChemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast CancerWho this might be right forBreast Cancer Beth Israel Deaconess Medical Center
Large-scale testing (Phase 3)Study completedNCT02437318What this trial is testingStudy Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment.Who this might be right forBreast Cancer Novartis Pharmaceuticals 572
Testing effectiveness (Phase 2)Study completedNCT00940225What this trial is testingStudy of Cabozantinib (XL184) in Adults With Advanced MalignanciesWho this might be right forSolid TumorsCancer Exelixis 730